Literature DB >> 33945039

Sufficient cardiac unloading by Impella 5.0 in left ventricular rupture following mitral valve replacement: a case report.

Yu Hohri1, Satoshi Numata2, Hidetake Kawajiri3, Takuma Kobayashi2, Kaichiro Manabe2, Koki Ikemoto2, Hitoshi Yaku2.   

Abstract

A 72-year-old woman presented with exertional dyspnea. Echocardiography revealed severe mitral valve stenosis; therefore, mitral valve replacement was performed using a bioprosthetic valve. However, left ventricular wall rupture occurred following mitral valve replacement. Under re-cardiac arrest, we found a left ventricular tear under the posterior annulus of the mitral valve. We repaired the left ventricular muscle using a bovine pericardial patch and implanted a bioprosthetic valve again. Postoperatively, we implanted an Impella 5.0 heart pump through the right axillary artery to ensure left ventricular wall unloading. Systemic blood flow depended almost completely on mechanical circulatory assistance until postoperative day 3. After the fourth postoperative day, we started weaning the patient from Impella 5.0. Finally, it was completely discontinued on the sixth postoperative day. After that, the patient's condition was stable, and she was discharged 44 days postoperatively. Impella 5.0 is a potentially beneficial device for left ventricular unloading in patients with left ventricular wall rupture following mitral valve replacement.
© 2021. The Japanese Society for Artificial Organs.

Entities:  

Keywords:  Cardiac unloading; Impella; Left ventricular rupture; Mechanical circulatory support; Mitral valve replacement

Mesh:

Year:  2021        PMID: 33945039     DOI: 10.1007/s10047-021-01272-6

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  1 in total

1.  Hemodynamic Effects of Mechanical Circulatory Support Devices in Ventricular Septal Defect.

Authors:  Mohit Pahuja; Benedikt Schrage; Dirk Westermann; Mir B Basir; Arthur Reshad Garan; Daniel Burkhoff
Journal:  Circ Heart Fail       Date:  2019-07-12       Impact factor: 8.790

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.